home / stock / scyx / scyx news

SCYX News and Press, SCYNEXIS Inc. From 03/30/23

Stock Information
Company Name: SCYNEXIS Inc.
Stock Symbol: SCYX
Market: NASDAQ
Website: scynexis.com
Menu
SCYX SCYX Quote SCYX Short SCYX News SCYX Articles SCYX Message Board
Get SCYX Alerts

News, Short Squeeze, Breakout and More Instantly...
SCYX - SCYNEXIS jumps 92% on licensing deal with GSK for anti-fungal agent

2023-03-30 07:40:40 ET GSK ( NYSE: GSK ) and New Jersey-based biotech SCYNEXIS ( NASDAQ: SCYX ) announced an exclusive license agreement on Thursday for Brexafemme (ibrexafungerp tablets), an FDA-approved treatment for certain fungal infections. In the pre-market, ...
SCYX - GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

Brexafemme complements GSK’s industry-leading infectious disease portfolio with an FDA approved treatment for vulvovaginal candidiasis SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties SCYNEXIS retains ri...

SCYX - Shell, UBS Group, Deutsche Bank among premarket losers' pack

2023-03-24 08:40:44 ET FiscalNote ( NOTE ) -16% . DiamondHead ( DHHC ) -16% . Rekor Systems ( REKR ) -13% on $10M stock offering . Deutsche Bank ( DB ) -11% as cost of default insurance spikes . Jaguar Health ( JAGX ) -11% ...

SCYX - Deadly fungal infection sweeps across U.S.

2023-03-22 10:27:20 ET A rare and often deadly fungal species is fast spreading across the U.S., infectious-disease specialists have warned. The fungus, a type of yeast called Candida auris , first detected about 15 years ago in Japan, has made a comeback in the U.S., accounting...
SCYX - 89bio, SCYNEXIS top healthcare gainers; NuCana, Nutex among losers

2023-03-22 10:02:09 ET Gainers: 89bio ( ETNB ) +38% . SCYNEXIS ( SCYX ) +21% . Athersys ( ATHX ) +20% .  Sol-Gel Technologies ( SLGL ) +19% . LifeMD ( LFMD ) +11% . Losers: NuCana ( NCNA ) -10% . Nutex Hea...

SCYX - AMC, SCYX and CDTX among pre market gainers

2023-03-22 08:21:40 ET 89bio ( ETNB ) +50% on topline data for NASH candidate. GameStop ( GME ) +48% on Q4 earnings. Telesis Bio ( TBIO ) +17% on Q4 earnings. Pyxis Oncology ( PYXS ) +11% on Q4 earnings. Ollie's Bargain O...

SCYX - ImmunityBio, NuCana top healthcare gainers; Altimmune, Check-Cap lead losers' pack

2023-03-21 10:03:51 ET Gainers: ImmunityBio ( IBRX ) +21% . NuCana ( NCNA ) +16% . Seres Therapeutics ( MCRB ) +14% . SCYNEXIS ( SCYX ) +13% . Corbus Pharmaceuticals ( CRBP ) +12% . Losers: Altimmune ( ALT ) ...
SCYX - CJJD, PRDS and BLBX among mid-day movers

Gainers: Reata Pharmaceuticals ( RETA ) +175% . OncoSec Medical ( ONCS ) +94% . B&G Foods ( BGS ) +30% . Nerdy ( NRDY ) +29% . SCYNEXIS ( SCYX ) +29% . Blackboxstocks ( BLBX ) +29% . Red Robin Gourmet Burgers ( RRGB ...

SCYX - Scynexis adds 23% most in over two years as Guggenheim says Buy

Scynexis ( NASDAQ: SCYX ) jumped ~23% in the morning hours Wednesday, marking the sharpest intraday gain since Nov. 2021 after Guggenheim launched its coverage with a Buy rating and an $8 per share target citing the potential of its antifungal treatment Brexafemme. In December, th...

SCYX - Scynexis: New rVVC Label And Black-Boxed Warning, Maintaining A Sell Rating

Summary Scynexis has performed terribly during 2022 due to continued disappointment in earnings and sales ramp. New labels, including black-boxed warnings, could further hamper the slow commercial adoption of VVC indication, especially in the retail setting. We do not believe rVVC w...
Previous 10 Next 10